Biologicals

Papers
(The H4-Index of Biologicals is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Aims and Scope/Editorial Board/Publishing Details38
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop28
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops24
Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products17
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model15
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA15
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis14
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency13
The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report13
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques13
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report12
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions11
Aims and Scope/Editorial Board/Publishing Details11
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab11
0.064035892486572